156 related articles for article (PubMed ID: 25886387)
1. Rare variants in MYD88, IRAK4 and IKBKG and susceptibility to invasive pneumococcal disease: a population-based case-control study.
Ellis MK; Elliott KS; Rautanen A; Crook DW; Hill AV; Chapman SJ
PLoS One; 2015; 10(4):e0123532. PubMed ID: 25886387
[TBL] [Abstract][Full Text] [Related]
2. Association of Polymorphisms in IRAK1, IRAK4 and MyD88, and Severe Invasive Pneumococcal Disease.
Carrasco-Colom J; Jordan I; Alsina L; Garcia-Garcia JJ; Cambra-Lasaosa FJ; Martín-Mateos MA; Juan M; Muñoz-Almagro C
Pediatr Infect Dis J; 2015 Sep; 34(9):1008-13. PubMed ID: 26075815
[TBL] [Abstract][Full Text] [Related]
3. Functional assessment of the mutational effects of human IRAK4 and MyD88 genes.
Yamamoto T; Tsutsumi N; Tochio H; Ohnishi H; Kubota K; Kato Z; Shirakawa M; Kondo N
Mol Immunol; 2014 Mar; 58(1):66-76. PubMed ID: 24316379
[TBL] [Abstract][Full Text] [Related]
4. IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease.
Ku CL; Picard C; Erdös M; Jeurissen A; Bustamante J; Puel A; von Bernuth H; Filipe-Santos O; Chang HH; Lawrence T; Raes M; Maródi L; Bossuyt X; Casanova JL
J Med Genet; 2007 Jan; 44(1):16-23. PubMed ID: 16950813
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of dysfunction of human variants of the IRAK4 kinase and a role for its kinase activity in interleukin-1 receptor signaling.
De S; Karim F; Kiessu E; Cushing L; Lin LL; Ghandil P; Hoarau C; Casanova JL; Puel A; Rao VR
J Biol Chem; 2018 Sep; 293(39):15208-15220. PubMed ID: 30115681
[TBL] [Abstract][Full Text] [Related]
6. Two human MYD88 variants, S34Y and R98C, interfere with MyD88-IRAK4-myddosome assembly.
George J; Motshwene PG; Wang H; Kubarenko AV; Rautanen A; Mills TC; Hill AV; Gay NJ; Weber AN
J Biol Chem; 2011 Jan; 286(2):1341-53. PubMed ID: 20966070
[TBL] [Abstract][Full Text] [Related]
7. Oncogenically active MYD88 mutations in human lymphoma.
Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
[TBL] [Abstract][Full Text] [Related]
8. Complete dependence on IRAK4 kinase activity in TLR2, but not TLR4, signaling pathways underlies decreased cytokine production and increased susceptibility to Streptococcus pneumoniae infection in IRAK4 kinase-inactive mice.
Pennini ME; Perkins DJ; Salazar AM; Lipsky M; Vogel SN
J Immunol; 2013 Jan; 190(1):307-16. PubMed ID: 23209321
[TBL] [Abstract][Full Text] [Related]
9. Conventional and Single-Molecule Targeted Sequencing Method for Specific Variant Detection in IKBKG while Bypassing the IKBKGP1 Pseudogene.
Frans G; Meert W; Van der Werff Ten Bosch J; Meyts I; Bossuyt X; Vermeesch JR; Hestand MS
J Mol Diagn; 2018 Mar; 20(2):195-202. PubMed ID: 29269280
[TBL] [Abstract][Full Text] [Related]
10. IRAK4 turns IL-10+ phospho-FOXO+ monocytes into pro-inflammatory cells by suppression of protein kinase B.
Over B; Ziegler S; Foermer S; Weber AN; Bode KA; Heeg K; Bekeredjian-Ding I
Eur J Immunol; 2013 Jun; 43(6):1630-42. PubMed ID: 23519847
[TBL] [Abstract][Full Text] [Related]
11. Cloning and functional characterization of IRAK4 in large yellow croaker (Larimichthys crocea) that associates with MyD88 but impairs NF-κB activation.
Zou PF; Huang XN; Yao CL; Sun QX; Li Y; Zhu Q; Yu ZX; Fan ZJ
Fish Shellfish Immunol; 2017 Apr; 63():452-464. PubMed ID: 27989863
[TBL] [Abstract][Full Text] [Related]
12. Identifying host genetic risk factors in the context of public health surveillance for invasive pneumococcal disease.
Lingappa JR; Dumitrescu L; Zimmer SM; Lynfield R; McNicholl JM; Messonnier NE; Whitney CG; Crawford DC
PLoS One; 2011; 6(8):e23413. PubMed ID: 21858107
[TBL] [Abstract][Full Text] [Related]
13. Clinical IRAK4 deficiency caused by homozygosity for the novel
Jia A; James E; Lu HY; Sharma M; Modi BP; Biggs CM; Hildebrand KJ; Chomyn A; Erdle S; Kular H; Turvey SE
Cold Spring Harb Mol Case Stud; 2020 Jun; 6(3):. PubMed ID: 32532880
[TBL] [Abstract][Full Text] [Related]
14. Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases.
Loiarro M; Gallo G; Fantò N; De Santis R; Carminati P; Ruggiero V; Sette C
J Biol Chem; 2009 Oct; 284(41):28093-28103. PubMed ID: 19679662
[TBL] [Abstract][Full Text] [Related]
15. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling.
Lin SC; Lo YC; Wu H
Nature; 2010 Jun; 465(7300):885-90. PubMed ID: 20485341
[TBL] [Abstract][Full Text] [Related]
16. Role of germline aberrations affecting
Weren RDA; van der Post RS; Vogelaar IP; van Krieken JH; Spruijt L; Lubinski J; Jakubowska A; Teodorczyk U; Aalfs CM; van Hest LP; Oliveira C; Kamping EJ; Schackert HK; Ranzani GN; Gómez García EB; Hes FJ; Holinski-Feder E; Genuardi M; Ausems MGEM; Sijmons RH; Wagner A; van der Kolk LE; Cats A; Bjørnevoll I; Hoogerbrugge N; Ligtenberg MJL
J Med Genet; 2018 Oct; 55(10):669-674. PubMed ID: 29330337
[TBL] [Abstract][Full Text] [Related]
17. A narrow repertoire of transcriptional modules responsive to pyogenic bacteria is impaired in patients carrying loss-of-function mutations in MYD88 or IRAK4.
Alsina L; Israelsson E; Altman MC; Dang KK; Ghandil P; Israel L; von Bernuth H; Baldwin N; Qin H; Jin Z; Banchereau R; Anguiano E; Ionan A; Abel L; Puel A; Picard C; Pascual V; Casanova JL; Chaussabel D
Nat Immunol; 2014 Dec; 15(12):1134-42. PubMed ID: 25344726
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of Imidazo[1,2-b]pyridazine IRAK4 inhibitors for the treatment of mutant MYD88 L265P diffuse large B-cell lymphoma.
Chen Y; Bai G; Ning Y; Cai S; Zhang T; Song P; Zhou J; Duan W; Ding J; Xie H; Zhang H
Eur J Med Chem; 2020 Mar; 190():112092. PubMed ID: 32014679
[TBL] [Abstract][Full Text] [Related]
19. Mannose-binding lectin gene, MBL2, polymorphisms are not associated with susceptibility to invasive pneumococcal disease in children.
Lundbo LF; Harboe ZB; Clausen LN; Hollegaard MV; Sørensen HT; Hougaard DM; Konradsen HB; Nørgaard M; Benfield T
Clin Infect Dis; 2014 Aug; 59(4):e66-71. PubMed ID: 24771334
[TBL] [Abstract][Full Text] [Related]
20. Genetic susceptibility to invasive pneumococcal disease.
Sangil A; Arranz MJ; Güerri-Fernández R; Pérez M; Monzón H; Payeras A; Andrés M; Torviso J; Ibañez L; Garau J; Calbo E
Infect Genet Evol; 2018 Apr; 59():126-131. PubMed ID: 29407193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
